DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,044 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,945,000 | +6.8% | 34,602 | -1.3% | 1.54% | +8.3% |
Q1 2019 | $4,628,000 | +24.2% | 35,052 | -3.0% | 1.42% | +3.8% |
Q4 2018 | $3,725,000 | -5.5% | 36,125 | -0.4% | 1.37% | +26.0% |
Q3 2018 | $3,940,000 | +10.8% | 36,259 | +0.6% | 1.09% | +5.8% |
Q2 2018 | $3,557,000 | +4.1% | 36,047 | +3.3% | 1.03% | +1.0% |
Q1 2018 | $3,418,000 | +4.6% | 34,911 | -0.8% | 1.02% | +6.9% |
Q4 2017 | $3,267,000 | +7.9% | 35,195 | -0.3% | 0.95% | +5.1% |
Q3 2017 | $3,027,000 | +2.7% | 35,289 | +1.0% | 0.91% | -3.5% |
Q2 2017 | $2,948,000 | -2.8% | 34,928 | -1.5% | 0.94% | -4.9% |
Q1 2017 | $3,033,000 | +8.7% | 35,467 | -1.0% | 0.99% | +2.6% |
Q4 2016 | $2,789,000 | -0.6% | 35,832 | +0.1% | 0.96% | -7.0% |
Q3 2016 | $2,805,000 | -22.3% | 35,780 | +0.1% | 1.04% | -25.8% |
Q2 2016 | $3,610,000 | +9.5% | 35,738 | +2.8% | 1.40% | +7.7% |
Q1 2016 | $3,298,000 | +1.9% | 34,764 | -0.2% | 1.30% | +5.3% |
Q4 2015 | $3,235,000 | +8.7% | 34,832 | -0.3% | 1.23% | +2.5% |
Q3 2015 | $2,976,000 | +70.3% | 34,931 | +71.0% | 1.20% | +95.5% |
Q2 2015 | $1,748,000 | +0.1% | 20,426 | -0.7% | 0.62% | +5.5% |
Q1 2015 | $1,747,000 | – | 20,575 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |